DPP IV inhibitors

Details DPP IV inhibitors DPP IV inhibitors

2005-03-01

2005-03-01

McKane, Joseph K. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S374000, C546S274100, C548S236000

Reexamination Certificate

active

06861440

ABSTRACT:
The present invention relates to compounds of formula (I)wherein R1, R2, and X are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance.

REFERENCES:
patent: 5455351 (1995-10-01), Kempf et al.
patent: 6011115 (2000-01-01), Miharu et al.
patent: 6110949 (2000-08-01), Villhauer
patent: 6124305 (2000-09-01), Villhauer
patent: 19616486 (1997-10-01), None
patent: 19616486 (1997-10-01), None
patent: 19834591 (2000-02-01), None
patent: WO 9501976 (1995-01-01), None
patent: WO 9610018 (1996-04-01), None
patent: WO 9819998 (1998-05-01), None
patent: WO 9938501 (1999-08-01), None
patent: WO 9938501 (1999-08-01), None
patent: WO 0008002 (2000-02-01), None
patent: WO 0034241 (2000-06-01), None
patent: WO 0119805 (2001-03-01), None
patent: WO 0134594 (2001-05-01), None
patent: WO 0140180 (2001-06-01), None
patent: WO 0155105 (2001-08-01), None
patent: WO 0162266 (2001-08-01), None
patent: WO 0230890 (2002-04-01), None
Schunack et al., Z. Naturforschung, 42b, pp. 238-242 (1987).
Lipp et al., Eur. J. Med. Chem., 30, pp. 219-225 (1995).
Horne et al., Heterocycles, 39, pp. 139-153, (1994).
Francis et al., Tetrahedron Letters, 28, pp. 5133-5136 (1987).
Ali et al., Pak. J. Sci. Ind. Res., 36, pp. 502-510 (1993).
Weintraub, P.M., J. Med. Chem, 15, pp. 419-420 (1972).
Goto et al., Chem. Pharm. Bull., 19, pp. 2050-2057 (1971).
Golfier et al., J. Heterocycl. Chem., 10, pp. 989-991 (1973).
Singh et al., Ind. J. Chem., 22B, pp. 1177-1178 (1983).
Carrera et al., Synlett, 1, p. 93-94 (1994).
Agarwal et al., Synth. Commun., 23, pp. 1101-1110 (1993).
Qizhuang et al., J. Med. Chem., 32, pp. 478-486 (1989).
Freedman et al., J. Heterocycl. Chem., 27, pp. 343-346 (1990).
Collins et al., J. Med. Chem., 41, pp. 5037-5054 (1998).
Novartis AG, Expert Opinion on Therapeutic Patents, Ashley Publications, GB, vol. 10, No. 12, pp. 1937-1942 (2000).

Affiliated with

Also associated with

Rating

DPP IV inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with DPP IV inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DPP IV inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3370598